News

Net profit of Indoco Remedies reported to Rs 64.99 crore in the quarter ended June 2026 as against net loss of Rs 35.79 crore during the previous quarter ended June 2025. Sales rose 8.21% to Rs 466.22 crore in the quarter ended June 2026 as against Rs 430.86 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales466.22430.86 8 OPM %8.804.07 - PBDT14.91-6.96 LP PBT-19.62-36.66 46 NP64.99-35.79 LP Powered by Capital Market - Live News

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 28 July 2026.

Indoco Remedies announced that Malta Medicines Authority had inspected Company`s manufacturing facility for solid oral dosage form (Plant I) located at Goa (Facility), from 19 November to 24 November 2025. The Facility has received EU GMP certification from the Malta Medicines Authority confirming that the Facility complies with the Good Manufacturing Practice requirements as referred in the EC Directive.

Indoco Remedies has announced today that the Malta Medicines Authority had inspected the Company`s manufacturing facility for solid oral dosage form (Unit I) located at Baddi from 29 January 2026 to 03 February 2026. The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good Manufacturing Practice requirements as referred in the EC Directive.

Net Loss of Indoco Remedies reported to Rs 21.64 crore in the quarter ended March 2026 as against net loss of Rs 40.39 crore during the previous quarter ended March 2025. Sales rose 18.76% to Rs 455.90 crore in the quarter ended March 2026 as against Rs 383.89 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 95.15 crore in the year ended March 2026 as against net loss of Rs 73.74 crore during the previous year ended March 2025. Sales rose 9.24% to Rs 1792.94 crore in the year ended March 2026 as against Rs 1641.29 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales455.90383.89 19 1792.941641.29 9 OPM %10.90-0.20 -7.916.05 - PBDT3.75-16.74 LP 22.8838.48 -41 PBT-28.74-45.52 37 -103.57-75.36 -37 NP-21.64-40.39 46 -95.15-73.74 -29 Powered by Capital Market - Live News